PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11813828-7	2002	Preincubation with 10 microM TMB-8 (an intracellular calcium sequester) also significantly suppressed IL-8 release in CSE- and C5a-treated HBEC, suggesting that intracellular calcium is required for CSE- and C5a-mediated IL-8 release.	8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate	29-34	complement C5a receptor 1	Homo sapiens	127-130	
11813828-7	2002	Preincubation with 10 microM TMB-8 (an intracellular calcium sequester) also significantly suppressed IL-8 release in CSE- and C5a-treated HBEC, suggesting that intracellular calcium is required for CSE- and C5a-mediated IL-8 release.	8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate	29-34	complement C5a receptor 1	Homo sapiens	208-211	
6814207-3	1982	The inhibition of FMLP- and C5a-induced lysosomal enzyme secretion by the intracellular Ca2+ antagonist, 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate (TMB-8) was additive to lowering extracellular [Ca2+f] from 10(-4) M to 10(-6) M or blocking plasma membrane Ca2+ flux with verapamil.	8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate	105-155	complement C5a receptor 1	Homo sapiens	28-31	
6814207-3	1982	The inhibition of FMLP- and C5a-induced lysosomal enzyme secretion by the intracellular Ca2+ antagonist, 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate (TMB-8) was additive to lowering extracellular [Ca2+f] from 10(-4) M to 10(-6) M or blocking plasma membrane Ca2+ flux with verapamil.	8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate	157-162	complement C5a receptor 1	Homo sapiens	28-31